Health Care/Hospital

Longevity and precision medicine driving the agenda at Abu Dhabi Global Health Week

* Global initiative addressing personalised and preventative health to be launched during the event ABU DHABI, UAE, April 10, 2025 /PRNewswire/ -- With rising global demand for more personalised and effective healthcare solutions, the Department of Health -Abu Dhabi (DoH) , the regulator of the...

2025-04-10 21:37 3589

Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer

CAMBRIDGE, Mass., April 10, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I TM), ranging from target validation and antibody discovery through preclinical research, today announced a research collaboration with Atossa ...

2025-04-10 20:00 2562

Fangzhou Showcases AI Governance Breakthroughs at Guangzhou Closed-Door Summit on Vertical-Specific AI Models

GUANGZHOU, China, April 9, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leading Internet healthcare solution provider, emerged as the sole digital health innovator invited to the Modern Industrial System Development Summit hosted by the Guangzhou Industrial Devel...

2025-04-10 11:07 4376

Amcor builds cutting-edge coating facility, enhancing healthcare packaging access in Asia Pacific

New facility enhances supply chain security, reduces lead times and supports customers' growth First in Asia equipped with advanced air knife coating technology First in Asia to produce both top and bottom substrates for medical device packaging ZURICH, April 9, 2025 /PRNewswire/ -- Amcor (NYSE...

2025-04-10 10:00 4548

Harbour BioMed Appoints Youchen Chen as Chief Financial Officer

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , April 9, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics focusing on immunology and oncology, today announced the appointment of...

2025-04-10 10:00 4501

APHRANEL Global Launch Meeting, in Shanghai China

APHRANEL Global Launch Meeting: Code Breaker, World Maker SHANGHAI, April 9, 2025 /PRNewswire/ -- On May 8, 2025——The APHRANEL Global Launch Meeting will be grandly held at the Shanghai World Reception Hall, overlooking the Bund! We warmly welcome esteemed experts, partners, investors, and consu...

2025-04-09 23:08 2752

Lunit Study in Radiology Highlights Trust Gap Between Radiologists and AI in Breast Cancer Screening

Despite strong performance from AI, fewer recalls from AI-flagged cases point to challenges in human-AI collaboration SEOUL, South Korea, April 9, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the p...

2025-04-09 21:00 2881

Ractigen's RAG-17 ALS Data Shines at AAN 2025: Earns Top Award, Phase I Advances

* Final results from an Investigator-Initiated Trial presented for the first time, demonstrating favorable safety, significant target engagement, and encouraging clinical & biomarker signals * Abstract honored with prestigious "Abstracts of Distinction" award by AAN Science Committee, recogni...

2025-04-09 20:00 2824

Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology

SEOUL, South Korea, April 9, 2025 /PRNewswire/ -- Darnatein, a wholly-owned subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), today announces that it has successfully secured an additional international patent for its protein-based osteoarthritis treatment technology, marking a significant step in...

2025-04-09 19:54 2724

GC Biopharma Receives MFDS Approval for World's First Recombinant Anthrax Vaccine

YONGIN, South Korea, April 9, 2025 /PRNewswire/ -- GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA). With the ap...

2025-04-09 12:00 2381

VARON Expands Access to Oxygen Therapy--Breathing Easier, Living Stronger

NEW YORK, April 8, 2025 /PRNewswire/ -- VARON, a leading provider of respiratory solutions, is expanding access to high-quality home oxygen concentrators, helping individuals with respiratory conditions maintain independence and an active lifestyle. For many, respirator...

2025-04-09 08:18 1990

Medit Reaffirms Commitment to American Dental Providers: No Price Increases for U.S. Customers

SEOUL, South Korea and NEWPORT BEACH, Calif., April 8, 2025 /PRNewswire/ -- Medit, a global leader in digital dentistry solutions and intraoral scanning technology, announced today that it will not raise suggested retail prices for its U.S. customers—reaffirming its commitment to accessibility, t...

2025-04-09 00:00 2722

GenScript Biotech Releases 2024 ESG Report, Highlighting Sustainability Practices and Progress

PISCATAWAY, N.J., April 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation (GenScript), a global leader in life sciences research, manufacturing technologies, and production services, has released its 2024 Environmental, Social, and Governance (ESG) report. The report highlights the Company's ...

2025-04-08 21:40 2435

MicuRx: 15 Clinical and Preclinical Research Studies to be Presented at ESCMID Global 2025

SHANGHAI, April 8, 2025 /PRNewswire/ -- The 2025 European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2025) will take place in Vienna from April 11 to 15, 2025. As one of the largest, most comprehensive, and influential global academic conferences in the fields of clin...

2025-04-08 15:38 2761

2025 ZGC Forum: Gala for Global Sci-tech Cooperation

BEIJING, April 7, 2025 /PRNewswire/ -- A report from Science and Technology Daily: The 2025 Zhongguancun Forum Annual Conference (2025 ZGC Forum), with a focus on new quality productive forces, concluded onMarch 31, with significant results and promotion of international sci-tech cooperation. &a...

2025-04-07 21:45 2262

Duality Bio Appoints Hua Mu as Global Chief Medical Officer

SHANGHAI, April 7, 2025 /PRNewswire/ -- DualityBio announced today that Dr. Hua Mu has joined the company as Global Chief Medical Officer (CMO). In this role, Dr. Mu will oversee the strategic planning, meticulous design, efficient execution, and comprehensive regulatory compliance of the company...

2025-04-07 12:52 2467

Luye Pharma Announces U.S. Launch of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Schizoaffective Disorder

PRINCETON, N.J., April 6, 2025 /PRNewswire/ -- Luye Pharma Group today announced that ERZOFRI® (paliperidone palmitate) extended-release injectable suspension is now available for commercial sale in the U.S. for the treatment of adults with schizophrenia and as a monotherapy or adjunct therapy fo...

2025-04-07 08:00 2418

The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine

CHENGDU, China, April 5, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced that the prestigious medical journalNature Medicine has published the results from the Phase III trial of its independently developed IL-4Rα antibody stapokibart, for th...

2025-04-06 10:12 3370

I Peace Launches Personalized iPS Cell Services and Longevity Treatment in the U.S.

– Age-Reversed Stem Cell Technology Now Available to the Public – PALO ALTO, Calif., April 5, 2025 /PRNewswire/ -- I Peace, Inc. ( https://ipeace.com/en/ ), a global pioneer in iPSC (induced pluripotent stem cell) technology, proudly announces the launch of its personalize...

2025-04-05 20:00 2969

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

HAIKOU, China, April 4, 2025 /PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Company") (NYSE American: CPHI) reported that it expects to implement a 1-for-10 reverse stock split on its common stock effectiveTuesday, April 15, 2025, with trading to begin on a split-adjusted basi...

2025-04-05 04:05 6083
1 ... 51525354555657 ... 310